Share price 199.60GBp -1.50 (delayed by at least 15 mins)

Portfolio

betapharm

betapharm
Investment type Buyouts
Region Germany
Status Former investment
View website

To view this content, JavaScript must be enabled, and you need the latest version of the Adobe Flash Player.

Nature of Business

A leader in the generics market, betapharm, founded in 1993, was the fourth largest generics company in Germany with approximately 4% market share. Located in Ausburg, Germany, betapharm marketed high-quality generic drugs focusing on long-term therapy products with high prescription rates.

3i acquired betapharm in 2004 and the company was successfully sold to India's Dr Reddy's in 2006 in a deal worth €480m.

Useful links

Read more...